All Comments by Todd E. Golde
- A Little Amyloid, A Lot of Trouble?
- Field Loses Chad Dickey, 40, to Cancer
- Immune Receptor May Smuggle α-Synuclein into Neurons, Hasten Proteopathy
- Dale Schenk, 59, Pioneer of Alzheimer’s Immunotherapy
- Immune Receptor May Smuggle α-Synuclein into Neurons, Hasten Proteopathy
- Lessons from a failed γ-secretase Alzheimer trial.
- Microglia and AD—Does the Inflammasome Drive Aβ Pathology?
- Novel γ-secretase enzyme modulators directly target presenilin protein.
- Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.
- AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
- Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
- Early Events in AD Mice as Targets for Therapy
- SfN: Channeling Selective Toxicity in Parkinson Disease
- SfN: R-Flurbiprofen Phase 2 Trial Results
- CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production.